Workup and Management for Chronic Abdominal Distension with Intermittent Diarrhea
This 21-year-old likely has a functional gastrointestinal disorder (most consistent with IBS-D or functional bloating/distension), but you must first exclude organic disease with targeted screening tests before making this diagnosis and initiating symptom-directed treatment.
Initial Diagnostic Approach
Mandatory Screening Tests
Start with these blood and stool tests to exclude organic disease 1:
- Complete blood count (to detect anemia suggesting celiac disease, IBD, or malignancy)
- Erythrocyte sedimentation rate and C-reactive protein (elevated ESR/CRP has high specificity for organic disease, particularly important in younger patients) 1
- Celiac serology (tissue transglutaminase IgA with total IgA level) 1
- Thyroid-stimulating hormone (suppressed TSH predicts hyperthyroidism causing diarrhea) 1
- Comprehensive metabolic panel (electrolytes, liver function, albumin, calcium) 2
- Stool studies: fecal calprotectin (for IBD), occult blood, ova and parasites 2
When to Pursue Endoscopy
Do NOT perform colonoscopy or sigmoidoscopy in this 21-year-old if the above screening tests are normal and there are no alarm features 2. Colonoscopy is recommended for patients over age 50, but in younger patients it should only be done if alarm features are present 2.
Alarm features requiring endoscopy include:
- Unintentional weight loss
- Rectal bleeding (not from hemorrhoids/fissures)
- Nocturnal diarrhea
- Family history of IBD, colon cancer, or celiac disease
- Iron deficiency anemia
- Symptom onset after age 50 3
Additional Testing Based on Symptom Pattern
Since this patient has diarrhea-predominant symptoms with bloating 2:
- Lactose breath test (for carbohydrate intolerance causing gas/bloating) 2
- Consider stool for Giardia if travel history or endemic area 2, 4
- Fecal calprotectin is particularly useful—if elevated, pursue endoscopy; if borderline, serial monitoring can guide management 5
Diagnosis
If screening tests are negative, diagnose functional disorder based on Rome IV criteria 2:
The patient's symptoms of:
- Hard/distended abdomen for one year
- Intermittent diarrhea
- Increased flatulence
- Daily bowel movements
These align with IBS-D or functional abdominal bloating/distension 2, 6, 7. The key is that functional disorders are diagnosed by excluding structural/biochemical abnormalities, not by exhaustive testing 2.
Management Strategy
Step 1: Education and Reassurance
Provide a confident, positive diagnosis once organic disease is excluded 2, 8. Explain that symptoms are real but not dangerous, and set realistic expectations that treatment targets symptom control, not cure.
Step 2: Dietary Modifications (First-Line)
Trial a low-FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) 5, 1. This addresses:
- Gas production from poorly absorbed carbohydrates
- Bloating and distension
- Diarrhea
Specific dietary advice 1:
- Reduce caffeine intake (coffee, energy drinks)
- Avoid sorbitol and fructose-containing foods
- Trial lactose elimination if breath test positive
- Ensure adequate fiber but avoid wheat bran if it worsens symptoms 2
Step 3: Pharmacotherapy for Diarrhea
For diarrhea and urgency, start loperamide 2, 9, 3. This is the most straightforward first-line agent with immediate symptom relief.
If loperamide fails, consider:
- Rifaximin (non-absorbable antibiotic, 550 mg three times daily for 14 days) 3
- Eluxadoline (100 mg twice daily) 3
- Alosetron (0.5-1 mg twice daily, requires special prescribing due to ischemic colitis risk) 3
Step 4: Treatment for Bloating/Distension
For persistent bloating and abdominal distension 6, 7:
- Antispasmodics (e.g., hyoscyamine, dicyclomine) for visceral hypersensitivity 2, 3
- Probiotics may help modulate microbiome 5
- Simethicone for gas symptoms (though evidence is limited)
Step 5: Neuromodulators for Refractory Symptoms
If symptoms persist despite above measures, use tricyclic antidepressants (e.g., amitriptyline 10-25 mg at bedtime, titrate up) 2, 3. TCAs have proven efficacy for abdominal pain and global IBS symptoms.
Avoid selective serotonin reuptake inhibitors—the guideline panel made a conditional recommendation AGAINST SSRIs due to lack of benefit 3.
Step 6: Behavioral Therapies
Consider cognitive behavioral therapy, gut-directed hypnotherapy, or mindfulness therapy if psychological factors are prominent or symptoms are refractory 2, 5, 9.
Follow-Up and Reassessment
Reevaluate in 3-6 weeks 2. If treatment is unsuccessful:
- Reassess for missed organic disease
- Consider additional testing (e.g., small bowel imaging, bile acid diarrhea testing with SeHCAT or serum C4/FGF19) 4
- Escalate pharmacotherapy or add behavioral interventions
Critical Pitfalls to Avoid
Do not over-investigate in young patients without alarm features—this increases costs, patient anxiety, and risk of false-positive results leading to unnecessary procedures 2, 1
Do not diagnose IBS without excluding celiac disease—it is common (0.5-1% prevalence) and easily missed 1
Do not use opiates for chronic pain—they worsen constipation and lead to dependence 5
Do not ignore the patient's quality of life impact—functional disorders significantly impair work, social activities, and daily functioning despite being "benign" 9
Do not assume all bloating is IBS—if distension is severe or progressive, consider structural complications, small intestinal bacterial overgrowth, or chronic pancreatitis 5